In addition to its important role in the cell cycle, CDK4 exerts immunomodulatory and immunogenic effects by negatively interfering in the expression of PD-L1 in tumor cells and also in the direct reduction of infiltrating T lymphocytes of the immune system.35 This evidence concerns the gene CDK4 and neoplasm.